Gad Soffer, EVP & Chief Strategy Officer at Atara Biotherapeutics, Inc. (ATRA), sold 12,674 shares at $15.13 ($192K) on 2017-05-15, disclosed to the SEC on 2017-05-17.
Open-market sale of $192k ATRA by EVP & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.13 | 7,000 | $106K | 55.1% |
| 2 | $15.19 | 5,674 | $86K | 44.9% |
| Total | $15.16 avg | 12,674 | $192K | 100% |
| Filing → |
| ATRA | SELL | 2017-08-17 | $141K | — | Filing → |
| ATRA | SELL | 2017-03-13 | $50K | — | Filing → |
| ATRA | SELL | 2017-02-16 | $334K | — | Filing → |